Eliem Therapeutics, Inc.

NASDAQ:ELYM

5.11 (USD) • At close October 2, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -73.897-35.119-45.244-47.48-20.668-6.547
Depreciation & Amortization -0.757001.84500
Deferred Income Tax 00-1.39-1.84500
Stock Based Compensation 5.55712.8066.9913.7370.7070
Change In Working Capital 03.7640.21-4.172-2.936-0.309
Accounts Receivables 000000
Inventory 000000
Accounts Payables -0.963-0.686-0.6530.15-0.0240.017
Other Working Capital 04.450.863-4.322-2.912-0.326
Other Non Cash Items 0-2.052.06411.8438.7991.848
Operating Cash Flow -15.562-20.599-37.369-36.072-14.098-5.008
Investing Activities:
Investments In Property Plant And Equipment 000000
Acquisitions Net -4.6450000.0080
Purchases Of Investments -132.197-58.449-87.963-114.9700
Sales Maturities Of Investments 20.75127.43122.403000
Other Investing Activites -50.0690.034-0.1158.070
Investing Cash Flow -121.09268.98134.44-114.978.0780
Financing Activities:
Debt Repayment 000000
Common Stock Issued 119.750.841083.1444.92526.243
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 10.9790.841094.0884.92526.243
Financing Cash Flow 130.7290.8410177.2324.92526.243
Other Information:
Effect Of Forex Changes On Cash 0.0420.304-0.4080.2450.359-0.012
Net Change In Cash -5.88349.527-3.33726.435-0.73621.223
Cash At End Of Period 87.22993.11243.58546.92220.48721.223